RxDoctor Payments Data

Rachel Mullins

Acute Care · Toledo, OHNPI 1043442064

Payments from drug & device makers

$2,259in general payments, 2019–2025

Across 98 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$249
  • Kerecis Limited$237
  • Johnson & Johnson$203
  • Silk Road Medical, Inc.$143
  • Terumo Medical Corporation$137
  • AstraZeneca$127
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$2,259100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,259 in reported general payments places this provider in the 85th percentile of 1,101 acute care providers in Ohio.

See all acute care providers in Ohio

Medicare billing

Part B allowed, 2024
$23,376
Medicare patients
198
Services billed
262

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$70,752
XareltoRivaroxaban22$18,987
Cilostazol42$639
ClopidogrelClopidogrel Bisulfate52$434
Doxycycline Hyclate20$310
Atorvastatin Calcium38$237
Buspirone Hcl11$130
Gabapentin13$108
Oxycodone Hcl12$99
Pantoprazole Sodium17$96
Fluticasone Propionate11$84
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$80
Triamcinolone Acetonide13$52
Azithromycin11$30
Prednisone16$29

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$122$70,752110 claims
Johnson & JohnsonXarelto$203$18,98722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,101 acute care providers in Ohio.

Other acute care in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →